nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucytosine—Nucleoside Analog—Azathioprine—systemic scleroderma	0.902	1	CiPCiCtD
Flucytosine—DNMT1—Budesonide—Mometasone—systemic scleroderma	0.000825	0.291	CbGdCrCtD
Flucytosine—DNMT1—Betamethasone—Mometasone—systemic scleroderma	0.000504	0.178	CbGdCrCtD
Flucytosine—DNMT1—Dexamethasone—Mometasone—systemic scleroderma	0.000504	0.178	CbGdCrCtD
Flucytosine—DNMT1—Budesonide—Prednisone—systemic scleroderma	0.000449	0.159	CbGdCrCtD
Flucytosine—Hallucination—Mycophenolic acid—systemic scleroderma	0.000298	0.00314	CcSEcCtD
Flucytosine—Renal failure—Lisinopril—systemic scleroderma	0.000295	0.00311	CcSEcCtD
Flucytosine—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.000295	0.0031	CcSEcCtD
Flucytosine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000294	0.0031	CcSEcCtD
Flucytosine—Anorexia—Mometasone—systemic scleroderma	0.000294	0.0031	CcSEcCtD
Flucytosine—Jaundice—Lisinopril—systemic scleroderma	0.000293	0.00309	CcSEcCtD
Flucytosine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000292	0.00308	CcSEcCtD
Flucytosine—Urticaria—Pentoxifylline—systemic scleroderma	0.000284	0.00299	CcSEcCtD
Flucytosine—Chest pain—Captopril—systemic scleroderma	0.000282	0.00298	CcSEcCtD
Flucytosine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000282	0.00298	CcSEcCtD
Flucytosine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000282	0.00298	CcSEcCtD
Flucytosine—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.00028	0.00296	CcSEcCtD
Flucytosine—Agranulocytosis—Lisinopril—systemic scleroderma	0.00028	0.00296	CcSEcCtD
Flucytosine—Paraesthesia—Mometasone—systemic scleroderma	0.000277	0.00292	CcSEcCtD
Flucytosine—Dry mouth—Captopril—systemic scleroderma	0.000276	0.00291	CcSEcCtD
Flucytosine—DNMT1—Dexamethasone—Prednisone—systemic scleroderma	0.000275	0.097	CbGdCrCtD
Flucytosine—DNMT1—Betamethasone—Prednisone—systemic scleroderma	0.000275	0.097	CbGdCrCtD
Flucytosine—Dyspnoea—Mometasone—systemic scleroderma	0.000275	0.0029	CcSEcCtD
Flucytosine—Confusional state—Captopril—systemic scleroderma	0.000273	0.00288	CcSEcCtD
Flucytosine—Hepatitis—Lisinopril—systemic scleroderma	0.00027	0.00284	CcSEcCtD
Flucytosine—Hallucination—Lisinopril—systemic scleroderma	0.000268	0.00283	CcSEcCtD
Flucytosine—Decreased appetite—Mometasone—systemic scleroderma	0.000268	0.00282	CcSEcCtD
Flucytosine—Anaemia—Azathioprine—systemic scleroderma	0.000267	0.00282	CcSEcCtD
Flucytosine—Fatigue—Mometasone—systemic scleroderma	0.000266	0.0028	CcSEcCtD
Flucytosine—Thrombocytopenia—Captopril—systemic scleroderma	0.000265	0.00279	CcSEcCtD
Flucytosine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000263	0.00277	CcSEcCtD
Flucytosine—Leukopenia—Azathioprine—systemic scleroderma	0.000259	0.00273	CcSEcCtD
Flucytosine—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.000259	0.00273	CcSEcCtD
Flucytosine—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.000258	0.00272	CcSEcCtD
Flucytosine—Anorexia—Captopril—systemic scleroderma	0.000258	0.00272	CcSEcCtD
Flucytosine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000257	0.00271	CcSEcCtD
Flucytosine—Asthenia—Pentoxifylline—systemic scleroderma	0.000256	0.0027	CcSEcCtD
Flucytosine—Pruritus—Pentoxifylline—systemic scleroderma	0.000253	0.00266	CcSEcCtD
Flucytosine—Anaemia—Leflunomide—systemic scleroderma	0.000253	0.00266	CcSEcCtD
Flucytosine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000252	0.00266	CcSEcCtD
Flucytosine—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00025	0.00264	CcSEcCtD
Flucytosine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000246	0.00259	CcSEcCtD
Flucytosine—Vertigo—Leflunomide—systemic scleroderma	0.000246	0.00259	CcSEcCtD
Flucytosine—Leukopenia—Leflunomide—systemic scleroderma	0.000245	0.00258	CcSEcCtD
Flucytosine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000244	0.00258	CcSEcCtD
Flucytosine—Body temperature increased—Mometasone—systemic scleroderma	0.000244	0.00257	CcSEcCtD
Flucytosine—Abdominal pain—Mometasone—systemic scleroderma	0.000244	0.00257	CcSEcCtD
Flucytosine—Paraesthesia—Captopril—systemic scleroderma	0.000243	0.00256	CcSEcCtD
Flucytosine—Dyspnoea—Captopril—systemic scleroderma	0.000241	0.00254	CcSEcCtD
Flucytosine—Anaemia—Mycophenolic acid—systemic scleroderma	0.000241	0.00254	CcSEcCtD
Flucytosine—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000238	0.0025	CcSEcCtD
Flucytosine—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000236	0.00249	CcSEcCtD
Flucytosine—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000236	0.00249	CcSEcCtD
Flucytosine—Decreased appetite—Captopril—systemic scleroderma	0.000235	0.00248	CcSEcCtD
Flucytosine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000235	0.00248	CcSEcCtD
Flucytosine—Vertigo—Mycophenolic acid—systemic scleroderma	0.000234	0.00247	CcSEcCtD
Flucytosine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000233	0.00246	CcSEcCtD
Flucytosine—Fatigue—Captopril—systemic scleroderma	0.000233	0.00246	CcSEcCtD
Flucytosine—Chest pain—Leflunomide—systemic scleroderma	0.000233	0.00245	CcSEcCtD
Flucytosine—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.000232	0.00244	CcSEcCtD
Flucytosine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000231	0.00244	CcSEcCtD
Flucytosine—Dry mouth—Leflunomide—systemic scleroderma	0.000228	0.0024	CcSEcCtD
Flucytosine—Vomiting—Pentoxifylline—systemic scleroderma	0.000227	0.00239	CcSEcCtD
Flucytosine—Psychotic disorder—Prednisone—systemic scleroderma	0.000226	0.00238	CcSEcCtD
Flucytosine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000226	0.00238	CcSEcCtD
Flucytosine—Rash—Pentoxifylline—systemic scleroderma	0.000225	0.00237	CcSEcCtD
Flucytosine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000225	0.00237	CcSEcCtD
Flucytosine—Headache—Pentoxifylline—systemic scleroderma	0.000224	0.00236	CcSEcCtD
Flucytosine—Feeling abnormal—Captopril—systemic scleroderma	0.000223	0.00235	CcSEcCtD
Flucytosine—Chest pain—Mycophenolic acid—systemic scleroderma	0.000222	0.00234	CcSEcCtD
Flucytosine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000221	0.00233	CcSEcCtD
Flucytosine—Asthenia—Mometasone—systemic scleroderma	0.000221	0.00233	CcSEcCtD
Flucytosine—Photosensitivity—Methotrexate—systemic scleroderma	0.00022	0.00232	CcSEcCtD
Flucytosine—Cardiac arrest—Prednisone—systemic scleroderma	0.00022	0.00232	CcSEcCtD
Flucytosine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000218	0.0023	CcSEcCtD
Flucytosine—Pruritus—Mometasone—systemic scleroderma	0.000218	0.0023	CcSEcCtD
Flucytosine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000217	0.00229	CcSEcCtD
Flucytosine—Anaemia—Lisinopril—systemic scleroderma	0.000217	0.00229	CcSEcCtD
Flucytosine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000215	0.00226	CcSEcCtD
Flucytosine—Abdominal pain—Captopril—systemic scleroderma	0.000214	0.00225	CcSEcCtD
Flucytosine—Body temperature increased—Captopril—systemic scleroderma	0.000214	0.00225	CcSEcCtD
Flucytosine—Anorexia—Leflunomide—systemic scleroderma	0.000213	0.00224	CcSEcCtD
Flucytosine—Nausea—Pentoxifylline—systemic scleroderma	0.000212	0.00224	CcSEcCtD
Flucytosine—Vertigo—Lisinopril—systemic scleroderma	0.000211	0.00222	CcSEcCtD
Flucytosine—Diarrhoea—Mometasone—systemic scleroderma	0.000211	0.00222	CcSEcCtD
Flucytosine—Hypokalaemia—Prednisone—systemic scleroderma	0.000211	0.00222	CcSEcCtD
Flucytosine—Leukopenia—Lisinopril—systemic scleroderma	0.00021	0.00222	CcSEcCtD
Flucytosine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000208	0.0022	CcSEcCtD
Flucytosine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000203	0.00214	CcSEcCtD
Flucytosine—Paraesthesia—Leflunomide—systemic scleroderma	0.0002	0.00211	CcSEcCtD
Flucytosine—Chest pain—Lisinopril—systemic scleroderma	0.0002	0.00211	CcSEcCtD
Flucytosine—Dyspnoea—Leflunomide—systemic scleroderma	0.000199	0.0021	CcSEcCtD
Flucytosine—Vomiting—Mometasone—systemic scleroderma	0.000196	0.00206	CcSEcCtD
Flucytosine—Dry mouth—Lisinopril—systemic scleroderma	0.000196	0.00206	CcSEcCtD
Flucytosine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000195	0.00205	CcSEcCtD
Flucytosine—Rash—Mometasone—systemic scleroderma	0.000194	0.00205	CcSEcCtD
Flucytosine—Asthenia—Captopril—systemic scleroderma	0.000194	0.00205	CcSEcCtD
Flucytosine—Dermatitis—Mometasone—systemic scleroderma	0.000194	0.00205	CcSEcCtD
Flucytosine—Decreased appetite—Leflunomide—systemic scleroderma	0.000194	0.00204	CcSEcCtD
Flucytosine—Confusional state—Lisinopril—systemic scleroderma	0.000193	0.00204	CcSEcCtD
Flucytosine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000193	0.00204	CcSEcCtD
Flucytosine—Headache—Mometasone—systemic scleroderma	0.000193	0.00203	CcSEcCtD
Flucytosine—Fatigue—Leflunomide—systemic scleroderma	0.000192	0.00203	CcSEcCtD
Flucytosine—Pruritus—Captopril—systemic scleroderma	0.000191	0.00202	CcSEcCtD
Flucytosine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000191	0.00201	CcSEcCtD
Flucytosine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00019	0.002	CcSEcCtD
Flucytosine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00019	0.002	CcSEcCtD
Flucytosine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000188	0.00198	CcSEcCtD
Flucytosine—Abdominal pain—Azathioprine—systemic scleroderma	0.000187	0.00197	CcSEcCtD
Flucytosine—Body temperature increased—Azathioprine—systemic scleroderma	0.000187	0.00197	CcSEcCtD
Flucytosine—Diarrhoea—Captopril—systemic scleroderma	0.000185	0.00195	CcSEcCtD
Flucytosine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000185	0.00195	CcSEcCtD
Flucytosine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000185	0.00195	CcSEcCtD
Flucytosine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000184	0.00194	CcSEcCtD
Flucytosine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000184	0.00194	CcSEcCtD
Flucytosine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000183	0.00193	CcSEcCtD
Flucytosine—Nausea—Mometasone—systemic scleroderma	0.000183	0.00193	CcSEcCtD
Flucytosine—Anorexia—Lisinopril—systemic scleroderma	0.000183	0.00193	CcSEcCtD
Flucytosine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000182	0.00192	CcSEcCtD
Flucytosine—Ataxia—Methotrexate—systemic scleroderma	0.000182	0.00192	CcSEcCtD
Flucytosine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000178	0.00188	CcSEcCtD
Flucytosine—Urticaria—Leflunomide—systemic scleroderma	0.000177	0.00187	CcSEcCtD
Flucytosine—Body temperature increased—Leflunomide—systemic scleroderma	0.000176	0.00186	CcSEcCtD
Flucytosine—Abdominal pain—Leflunomide—systemic scleroderma	0.000176	0.00186	CcSEcCtD
Flucytosine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000175	0.00185	CcSEcCtD
Flucytosine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000175	0.00185	CcSEcCtD
Flucytosine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000175	0.00184	CcSEcCtD
Flucytosine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000174	0.00184	CcSEcCtD
Flucytosine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000174	0.00183	CcSEcCtD
Flucytosine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000174	0.00183	CcSEcCtD
Flucytosine—Paraesthesia—Lisinopril—systemic scleroderma	0.000172	0.00181	CcSEcCtD
Flucytosine—Vomiting—Captopril—systemic scleroderma	0.000172	0.00181	CcSEcCtD
Flucytosine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000171	0.00181	CcSEcCtD
Flucytosine—Dyspnoea—Lisinopril—systemic scleroderma	0.000171	0.0018	CcSEcCtD
Flucytosine—Rash—Captopril—systemic scleroderma	0.000171	0.0018	CcSEcCtD
Flucytosine—Dermatitis—Captopril—systemic scleroderma	0.00017	0.0018	CcSEcCtD
Flucytosine—Headache—Captopril—systemic scleroderma	0.00017	0.00179	CcSEcCtD
Flucytosine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000169	0.00178	CcSEcCtD
Flucytosine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000168	0.00177	CcSEcCtD
Flucytosine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000168	0.00177	CcSEcCtD
Flucytosine—Decreased appetite—Lisinopril—systemic scleroderma	0.000167	0.00176	CcSEcCtD
Flucytosine—Eosinophilia—Methotrexate—systemic scleroderma	0.000166	0.00175	CcSEcCtD
Flucytosine—Fatigue—Lisinopril—systemic scleroderma	0.000165	0.00174	CcSEcCtD
Flucytosine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000164	0.00173	CcSEcCtD
Flucytosine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000164	0.00173	CcSEcCtD
Flucytosine—Diarrhoea—Azathioprine—systemic scleroderma	0.000162	0.0017	CcSEcCtD
Flucytosine—Haemoglobin—Prednisone—systemic scleroderma	0.000161	0.0017	CcSEcCtD
Flucytosine—Nausea—Captopril—systemic scleroderma	0.000161	0.00169	CcSEcCtD
Flucytosine—Haemorrhage—Prednisone—systemic scleroderma	0.00016	0.00169	CcSEcCtD
Flucytosine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00016	0.00169	CcSEcCtD
Flucytosine—Asthenia—Leflunomide—systemic scleroderma	0.00016	0.00169	CcSEcCtD
Flucytosine—Hallucination—Prednisone—systemic scleroderma	0.000159	0.00168	CcSEcCtD
Flucytosine—Pancytopenia—Methotrexate—systemic scleroderma	0.000159	0.00167	CcSEcCtD
Flucytosine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000158	0.00166	CcSEcCtD
Flucytosine—Pruritus—Leflunomide—systemic scleroderma	0.000158	0.00166	CcSEcCtD
Flucytosine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000157	0.00165	CcSEcCtD
Flucytosine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000153	0.00161	CcSEcCtD
Flucytosine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000153	0.00161	CcSEcCtD
Flucytosine—Diarrhoea—Leflunomide—systemic scleroderma	0.000153	0.00161	CcSEcCtD
Flucytosine—Urticaria—Lisinopril—systemic scleroderma	0.000152	0.0016	CcSEcCtD
Flucytosine—Abdominal pain—Lisinopril—systemic scleroderma	0.000151	0.0016	CcSEcCtD
Flucytosine—Body temperature increased—Lisinopril—systemic scleroderma	0.000151	0.0016	CcSEcCtD
Flucytosine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000151	0.00159	CcSEcCtD
Flucytosine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000151	0.00159	CcSEcCtD
Flucytosine—Vomiting—Azathioprine—systemic scleroderma	0.00015	0.00158	CcSEcCtD
Flucytosine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00015	0.00158	CcSEcCtD
Flucytosine—Rash—Azathioprine—systemic scleroderma	0.000149	0.00157	CcSEcCtD
Flucytosine—Dermatitis—Azathioprine—systemic scleroderma	0.000149	0.00157	CcSEcCtD
Flucytosine—Headache—Azathioprine—systemic scleroderma	0.000148	0.00156	CcSEcCtD
Flucytosine—Renal failure—Methotrexate—systemic scleroderma	0.000147	0.00155	CcSEcCtD
Flucytosine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000146	0.00154	CcSEcCtD
Flucytosine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000146	0.00153	CcSEcCtD
Flucytosine—Vomiting—Leflunomide—systemic scleroderma	0.000142	0.00149	CcSEcCtD
Flucytosine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000141	0.00149	CcSEcCtD
Flucytosine—Rash—Leflunomide—systemic scleroderma	0.000141	0.00148	CcSEcCtD
Flucytosine—Dermatitis—Leflunomide—systemic scleroderma	0.00014	0.00148	CcSEcCtD
Flucytosine—Nausea—Azathioprine—systemic scleroderma	0.00014	0.00148	CcSEcCtD
Flucytosine—Headache—Leflunomide—systemic scleroderma	0.00014	0.00147	CcSEcCtD
Flucytosine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000139	0.00147	CcSEcCtD
Flucytosine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000138	0.00146	CcSEcCtD
Flucytosine—Asthenia—Lisinopril—systemic scleroderma	0.000137	0.00145	CcSEcCtD
Flucytosine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000137	0.00145	CcSEcCtD
Flucytosine—Pruritus—Lisinopril—systemic scleroderma	0.000136	0.00143	CcSEcCtD
Flucytosine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000135	0.00143	CcSEcCtD
Flucytosine—Haemoglobin—Methotrexate—systemic scleroderma	0.000135	0.00142	CcSEcCtD
Flucytosine—Rash—Mycophenolic acid—systemic scleroderma	0.000134	0.00141	CcSEcCtD
Flucytosine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000134	0.00141	CcSEcCtD
Flucytosine—Hepatitis—Methotrexate—systemic scleroderma	0.000134	0.00141	CcSEcCtD
Flucytosine—Haemorrhage—Methotrexate—systemic scleroderma	0.000134	0.00141	CcSEcCtD
Flucytosine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000133	0.00141	CcSEcCtD
Flucytosine—Headache—Mycophenolic acid—systemic scleroderma	0.000133	0.0014	CcSEcCtD
Flucytosine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000133	0.0014	CcSEcCtD
Flucytosine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000133	0.0014	CcSEcCtD
Flucytosine—Nausea—Leflunomide—systemic scleroderma	0.000132	0.0014	CcSEcCtD
Flucytosine—Diarrhoea—Lisinopril—systemic scleroderma	0.000131	0.00138	CcSEcCtD
Flucytosine—Anaemia—Prednisone—systemic scleroderma	0.000129	0.00136	CcSEcCtD
Flucytosine—Nausea—Mycophenolic acid—systemic scleroderma	0.000126	0.00133	CcSEcCtD
Flucytosine—Vertigo—Prednisone—systemic scleroderma	0.000125	0.00132	CcSEcCtD
Flucytosine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000124	0.0013	CcSEcCtD
Flucytosine—Vomiting—Lisinopril—systemic scleroderma	0.000122	0.00128	CcSEcCtD
Flucytosine—Rash—Lisinopril—systemic scleroderma	0.000121	0.00127	CcSEcCtD
Flucytosine—Convulsion—Prednisone—systemic scleroderma	0.000121	0.00127	CcSEcCtD
Flucytosine—Dermatitis—Lisinopril—systemic scleroderma	0.000121	0.00127	CcSEcCtD
Flucytosine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00012	0.00127	CcSEcCtD
Flucytosine—Headache—Lisinopril—systemic scleroderma	0.00012	0.00127	CcSEcCtD
Flucytosine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000119	0.00125	CcSEcCtD
Flucytosine—DNMT1—connective tissue—systemic scleroderma	0.000118	0.255	CbGeAlD
Flucytosine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000115	0.00121	CcSEcCtD
Flucytosine—Nausea—Lisinopril—systemic scleroderma	0.000114	0.0012	CcSEcCtD
Flucytosine—Anorexia—Prednisone—systemic scleroderma	0.000108	0.00114	CcSEcCtD
Flucytosine—Anaemia—Methotrexate—systemic scleroderma	0.000108	0.00114	CcSEcCtD
Flucytosine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000107	0.00113	CcSEcCtD
Flucytosine—DNMT1—skin of body—systemic scleroderma	0.000107	0.231	CbGeAlD
Flucytosine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000106	0.00112	CcSEcCtD
Flucytosine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000106	0.00111	CcSEcCtD
Flucytosine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000105	0.00111	CcSEcCtD
Flucytosine—Vertigo—Methotrexate—systemic scleroderma	0.000105	0.0011	CcSEcCtD
Flucytosine—Leukopenia—Methotrexate—systemic scleroderma	0.000104	0.0011	CcSEcCtD
Flucytosine—Paraesthesia—Prednisone—systemic scleroderma	0.000102	0.00108	CcSEcCtD
Flucytosine—Convulsion—Methotrexate—systemic scleroderma	0.000101	0.00106	CcSEcCtD
Flucytosine—Nausea—Mycophenolate mofetil—systemic scleroderma	9.97e-05	0.00105	CcSEcCtD
Flucytosine—Chest pain—Methotrexate—systemic scleroderma	9.92e-05	0.00105	CcSEcCtD
Flucytosine—Decreased appetite—Prednisone—systemic scleroderma	9.89e-05	0.00104	CcSEcCtD
Flucytosine—Fatigue—Prednisone—systemic scleroderma	9.81e-05	0.00103	CcSEcCtD
Flucytosine—Confusional state—Methotrexate—systemic scleroderma	9.59e-05	0.00101	CcSEcCtD
Flucytosine—Feeling abnormal—Prednisone—systemic scleroderma	9.38e-05	0.000989	CcSEcCtD
Flucytosine—Thrombocytopenia—Methotrexate—systemic scleroderma	9.31e-05	0.000982	CcSEcCtD
Flucytosine—Gastrointestinal pain—Prednisone—systemic scleroderma	9.31e-05	0.000981	CcSEcCtD
Flucytosine—Anorexia—Methotrexate—systemic scleroderma	9.07e-05	0.000956	CcSEcCtD
Flucytosine—Urticaria—Prednisone—systemic scleroderma	9.04e-05	0.000953	CcSEcCtD
Flucytosine—Body temperature increased—Prednisone—systemic scleroderma	9e-05	0.000948	CcSEcCtD
Flucytosine—Abdominal pain—Prednisone—systemic scleroderma	9e-05	0.000948	CcSEcCtD
Flucytosine—Paraesthesia—Methotrexate—systemic scleroderma	8.54e-05	0.0009	CcSEcCtD
Flucytosine—DNMT1—digestive system—systemic scleroderma	8.53e-05	0.184	CbGeAlD
Flucytosine—Dyspnoea—Methotrexate—systemic scleroderma	8.48e-05	0.000894	CcSEcCtD
Flucytosine—Hypersensitivity—Prednisone—systemic scleroderma	8.39e-05	0.000884	CcSEcCtD
Flucytosine—Decreased appetite—Methotrexate—systemic scleroderma	8.27e-05	0.000872	CcSEcCtD
Flucytosine—Fatigue—Methotrexate—systemic scleroderma	8.2e-05	0.000864	CcSEcCtD
Flucytosine—Asthenia—Prednisone—systemic scleroderma	8.17e-05	0.000861	CcSEcCtD
Flucytosine—DNMT1—tendon—systemic scleroderma	8.12e-05	0.176	CbGeAlD
Flucytosine—Pruritus—Prednisone—systemic scleroderma	8.05e-05	0.000849	CcSEcCtD
Flucytosine—Feeling abnormal—Methotrexate—systemic scleroderma	7.84e-05	0.000826	CcSEcCtD
Flucytosine—Diarrhoea—Prednisone—systemic scleroderma	7.79e-05	0.000821	CcSEcCtD
Flucytosine—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.78e-05	0.00082	CcSEcCtD
Flucytosine—Urticaria—Methotrexate—systemic scleroderma	7.56e-05	0.000797	CcSEcCtD
Flucytosine—Abdominal pain—Methotrexate—systemic scleroderma	7.52e-05	0.000793	CcSEcCtD
Flucytosine—Body temperature increased—Methotrexate—systemic scleroderma	7.52e-05	0.000793	CcSEcCtD
Flucytosine—Vomiting—Prednisone—systemic scleroderma	7.24e-05	0.000763	CcSEcCtD
Flucytosine—Rash—Prednisone—systemic scleroderma	7.18e-05	0.000756	CcSEcCtD
Flucytosine—Dermatitis—Prednisone—systemic scleroderma	7.17e-05	0.000756	CcSEcCtD
Flucytosine—Headache—Prednisone—systemic scleroderma	7.13e-05	0.000752	CcSEcCtD
Flucytosine—DNMT1—lung—systemic scleroderma	7.13e-05	0.154	CbGeAlD
Flucytosine—Hypersensitivity—Methotrexate—systemic scleroderma	7.01e-05	0.000739	CcSEcCtD
Flucytosine—Asthenia—Methotrexate—systemic scleroderma	6.82e-05	0.000719	CcSEcCtD
Flucytosine—Nausea—Prednisone—systemic scleroderma	6.76e-05	0.000713	CcSEcCtD
Flucytosine—Pruritus—Methotrexate—systemic scleroderma	6.73e-05	0.000709	CcSEcCtD
Flucytosine—Diarrhoea—Methotrexate—systemic scleroderma	6.51e-05	0.000686	CcSEcCtD
Flucytosine—Vomiting—Methotrexate—systemic scleroderma	6.05e-05	0.000638	CcSEcCtD
Flucytosine—Rash—Methotrexate—systemic scleroderma	6e-05	0.000632	CcSEcCtD
Flucytosine—Dermatitis—Methotrexate—systemic scleroderma	5.99e-05	0.000632	CcSEcCtD
Flucytosine—Headache—Methotrexate—systemic scleroderma	5.96e-05	0.000628	CcSEcCtD
Flucytosine—Nausea—Methotrexate—systemic scleroderma	5.65e-05	0.000596	CcSEcCtD
